JP2010505482A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010505482A5 JP2010505482A5 JP2009530811A JP2009530811A JP2010505482A5 JP 2010505482 A5 JP2010505482 A5 JP 2010505482A5 JP 2009530811 A JP2009530811 A JP 2009530811A JP 2009530811 A JP2009530811 A JP 2009530811A JP 2010505482 A5 JP2010505482 A5 JP 2010505482A5
- Authority
- JP
- Japan
- Prior art keywords
- spinal
- implant
- retention factor
- nucleus implant
- cartilage differentiation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007943 implant Substances 0.000 claims 14
- 210000000845 cartilage Anatomy 0.000 claims 8
- 230000004069 differentiation Effects 0.000 claims 8
- 230000014759 maintenance of location Effects 0.000 claims 8
- 239000000203 mixture Substances 0.000 claims 8
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 102100022185 Melanoma-derived growth regulatory protein Human genes 0.000 claims 4
- 101710195116 Melanoma-derived growth regulatory protein Proteins 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 4
- 210000000278 spinal cord Anatomy 0.000 claims 4
- 238000009472 formulation Methods 0.000 claims 3
- 238000002513 implantation Methods 0.000 claims 3
- 235000018102 proteins Nutrition 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 208000008765 Sciatica Diseases 0.000 claims 2
- 235000001014 amino acid Nutrition 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 230000006378 damage Effects 0.000 claims 2
- 208000008035 Back Pain Diseases 0.000 claims 1
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 claims 1
- 206010050296 Intervertebral disc protrusion Diseases 0.000 claims 1
- 206010028570 Myelopathy Diseases 0.000 claims 1
- 206010037779 Radiculopathy Diseases 0.000 claims 1
- 208000029033 Spinal Cord disease Diseases 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 230000001195 anabolic effect Effects 0.000 claims 1
- 210000004899 c-terminal region Anatomy 0.000 claims 1
- 230000003848 cartilage regeneration Effects 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 210000001612 chondrocyte Anatomy 0.000 claims 1
- 230000002648 chondrogenic effect Effects 0.000 claims 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims 1
- 201000002972 idiopathic scoliosis Diseases 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 239000002502 liposome Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 208000020431 spinal cord injury Diseases 0.000 claims 1
- 208000005198 spinal stenosis Diseases 0.000 claims 1
- 238000013268 sustained release Methods 0.000 claims 1
- 239000012730 sustained-release form Substances 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06021093.7 | 2006-10-06 | ||
| EP06021093 | 2006-10-06 | ||
| PCT/EP2007/008660 WO2008040557A1 (en) | 2006-10-06 | 2007-10-05 | A spinal nucleus pulposus implant |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010505482A JP2010505482A (ja) | 2010-02-25 |
| JP2010505482A5 true JP2010505482A5 (https=) | 2010-11-25 |
| JP5484059B2 JP5484059B2 (ja) | 2014-05-07 |
Family
ID=38910893
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009530810A Expired - Fee Related JP5404402B2 (ja) | 2006-10-06 | 2007-10-05 | 医薬適用のための乾燥した再構成したベシクル形成 |
| JP2009530811A Expired - Fee Related JP5484059B2 (ja) | 2006-10-06 | 2007-10-05 | 脊髄核インプラント |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009530810A Expired - Fee Related JP5404402B2 (ja) | 2006-10-06 | 2007-10-05 | 医薬適用のための乾燥した再構成したベシクル形成 |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US9526761B2 (https=) |
| EP (2) | EP2086507B1 (https=) |
| JP (2) | JP5404402B2 (https=) |
| KR (1) | KR101333279B1 (https=) |
| CN (3) | CN102940878A (https=) |
| CA (1) | CA2664637C (https=) |
| CY (1) | CY1113934T1 (https=) |
| DK (1) | DK2081551T3 (https=) |
| ES (2) | ES2708851T3 (https=) |
| HR (1) | HRP20130328T1 (https=) |
| PL (1) | PL2081551T3 (https=) |
| PT (1) | PT2081551E (https=) |
| RS (1) | RS52706B (https=) |
| RU (1) | RU2443412C2 (https=) |
| SI (1) | SI2081551T1 (https=) |
| TW (1) | TWI455731B (https=) |
| WO (2) | WO2008040556A1 (https=) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8361067B2 (en) | 2002-09-30 | 2013-01-29 | Relievant Medsystems, Inc. | Methods of therapeutically heating a vertebral body to treat back pain |
| US6907884B2 (en) | 2002-09-30 | 2005-06-21 | Depay Acromed, Inc. | Method of straddling an intraosseous nerve |
| US7258690B2 (en) | 2003-03-28 | 2007-08-21 | Relievant Medsystems, Inc. | Windowed thermal ablation probe |
| EP1868539A2 (en) | 2005-04-15 | 2007-12-26 | Musculoskeletal Transplant Foundation | Vertebral disc repair |
| WO2008013763A2 (en) | 2006-07-25 | 2008-01-31 | Musculoskeletal Transplant Foundation | Packed demineralized cancellous tissue forms for disc nucleus augmentation, restoration, or replacement and methods of implantation |
| US10028753B2 (en) | 2008-09-26 | 2018-07-24 | Relievant Medsystems, Inc. | Spine treatment kits |
| AU2009296474B2 (en) | 2008-09-26 | 2015-07-02 | Relievant Medsystems, Inc. | Systems and methods for navigating an instrument through bone |
| EP3351625A1 (en) | 2010-02-18 | 2018-07-25 | Osiris Therapeutics, Inc. | Methods of manufacture of immunocompatible amniotic membrane products |
| BR112012027361A2 (pt) * | 2010-04-27 | 2021-04-27 | Scil Technology Gmbh | formulação mia/cd-rap estável. |
| WO2013101772A1 (en) | 2011-12-30 | 2013-07-04 | Relievant Medsystems, Inc. | Systems and methods for treating back pain |
| US20130202682A1 (en) * | 2012-01-24 | 2013-08-08 | The Trustees Of Columbia University In The City Of New York | Synthetic matrix vesicles for biomimetic mineralization |
| RU2677658C2 (ru) * | 2012-07-05 | 2019-01-18 | Тайвэн Липосом Ко, Лтд. | Способы лечения артрита |
| US10588691B2 (en) | 2012-09-12 | 2020-03-17 | Relievant Medsystems, Inc. | Radiofrequency ablation of tissue within a vertebral body |
| EP2914186B1 (en) | 2012-11-05 | 2019-03-13 | Relievant Medsystems, Inc. | Systems for creating curved paths through bone and modulating nerves within the bone |
| US9724151B2 (en) | 2013-08-08 | 2017-08-08 | Relievant Medsystems, Inc. | Modulating nerves within bone using bone fasteners |
| US10159646B2 (en) * | 2013-08-12 | 2018-12-25 | Altum-Avro Pharma Partnership | Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery |
| US8986732B2 (en) | 2013-08-12 | 2015-03-24 | Helix Biopharma Corporation | Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery |
| EP3233136B8 (en) * | 2014-12-18 | 2019-04-10 | Bracco Suisse SA | Targeted gas-filled microvesicles formulation |
| AU2016256979B2 (en) | 2015-05-04 | 2021-01-28 | Genfit | Method for preparing transmembrane pH-gradient vesicles |
| JP6976254B2 (ja) * | 2015-09-18 | 2021-12-08 | バイオネット ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツングBioNet Pharma GmbH | Ｃｄ−ｒａｐ前駆体タンパク質の使用による、ｃｄ−ｒａｐの製造方法における発現およびフォールディングの改善 |
| US20190111178A1 (en) * | 2016-04-04 | 2019-04-18 | Gu Ventures Ab | Methods and compositions for the treatment of intervertebral disc herniation |
| EP3618836A4 (en) * | 2017-04-25 | 2021-01-13 | Adjuvance Technologies, Inc. | TRITERPENSAPONINALOGA |
| MX393126B (es) * | 2017-08-28 | 2025-03-24 | Tlc Biopharmaceuticals Inc | Composiciones anestesicas de liberacion sostenida, y metodos de preparacion de las mismas |
| WO2019055901A1 (en) * | 2017-09-18 | 2019-03-21 | North Carolina State University | ARTIFICIAL β CELLS AND METHODS OF USE |
| KR102649069B1 (ko) | 2018-05-31 | 2024-03-19 | 주식회사 엑소코바이오 | 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 안면 홍조 개선용 조성물 |
| JP7079984B2 (ja) | 2018-07-28 | 2022-06-03 | エクソコバイオ インコーポレイテッド | エキソソームの凍結乾燥方法 |
| KR102163806B1 (ko) * | 2018-07-30 | 2020-10-07 | 주식회사 엑소코바이오 | 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 피지분비 감소용 조성물 |
| CN113166783B (zh) | 2018-10-09 | 2024-10-11 | 不列颠哥伦比亚大学 | 包含无有机溶剂和去污剂的转染活性囊泡的组合物和系统以及与之相关的方法 |
| AU2020346827B2 (en) | 2019-09-12 | 2026-03-12 | Relievant Medsystems, Inc. | Systems and methods for tissue modulation |
| AU2021306313A1 (en) | 2020-07-10 | 2023-03-02 | Relievant Medsystems, Inc. | Vertebral denervation in conjunction with vertebral fusion |
| US12082876B1 (en) | 2020-09-28 | 2024-09-10 | Relievant Medsystems, Inc. | Introducer drill |
| EP4268150A4 (en) | 2020-12-22 | 2024-12-18 | Relievant Medsystems, Inc. | PREDICTION OF CANDIDATES FOR SPINAL CORD NEUROMODULATION |
| US12433668B1 (en) | 2021-11-08 | 2025-10-07 | Relievant Medsystems, Inc. | Impedance stoppage mitigation during radiofrequency tissue ablation procedures |
| CN113995852B (zh) * | 2021-11-08 | 2024-01-30 | 河北大学 | Arg-脂质体微囊、微囊包封的鱼精蛋白-siRNA复合体及其制备方法和应用 |
| CN221431621U (zh) * | 2023-07-10 | 2024-07-30 | 常州富谦生物科技有限公司 | 一种多层膜结构 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH621479A5 (https=) * | 1977-08-05 | 1981-02-13 | Battelle Memorial Institute | |
| FR2416008A1 (fr) * | 1978-02-02 | 1979-08-31 | Oreal | Lyophilisats de liposomes |
| IL79114A (en) * | 1985-08-07 | 1990-09-17 | Allergan Pharma | Method and composition for making liposomes |
| FR2591105B1 (fr) * | 1985-12-11 | 1989-03-24 | Moet Hennessy Rech | Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide. |
| US4897353A (en) * | 1986-03-13 | 1990-01-30 | University Of Southwestern Louisiana | Cryogenic protection of phosphofructokinase using amino acids and zinc ions |
| US5709879A (en) * | 1990-06-29 | 1998-01-20 | Chiron Corporation | Vaccine compositions containing liposomes |
| EP0543871A1 (en) | 1990-08-08 | 1993-06-02 | Liposome Technology, Inc. | Stable doxorubicin/liposome composition |
| CA2120197A1 (en) * | 1993-04-02 | 1994-10-03 | Kenji Endo | Stable aqueous dispersions containing liposomes |
| GB9320668D0 (en) | 1993-10-07 | 1993-11-24 | Secr Defence | Liposomes containing particulare materials |
| US6066331A (en) * | 1994-07-08 | 2000-05-23 | Barenholz; Yechezkel | Method for preparation of vesicles loaded with biological structures, biopolymers and/or oligomers |
| IL115199A (en) | 1995-09-07 | 2005-05-17 | Opperbas Holding Bv | Composition comprising a polynucleic acid molecule in a liposome and method using said composition |
| US6287590B1 (en) * | 1997-10-02 | 2001-09-11 | Esperion Therapeutics, Inc. | Peptide/lipid complex formation by co-lyophilization |
| AU5702099A (en) * | 1998-09-01 | 2000-03-21 | Millennium Pharmaceuticals, Inc. | A novel protein related to melanoma-inhibiting protein and uses thereof |
| EP1025871A1 (en) * | 1999-01-28 | 2000-08-09 | F. Hoffmann-La Roche Ag | Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair |
| US7435260B2 (en) * | 1999-08-13 | 2008-10-14 | Ferree Bret A | Use of morphogenetic proteins to treat human disc disease |
| AU774481B2 (en) * | 1999-12-06 | 2004-07-01 | Warsaw Orthopedic, Inc. | Intervertebral disc treatment devices and methods |
| CA2462376C (en) * | 2001-10-03 | 2010-12-14 | Celator Technologies Inc. | Liposome loading with metal ions |
| WO2003099830A2 (en) * | 2002-05-24 | 2003-12-04 | Neopharm, Inc. | Cardiolipin compositions, methods of preparation and use |
| US7169405B2 (en) * | 2003-08-06 | 2007-01-30 | Warsaw Orthopedic, Inc. | Methods and devices for the treatment of intervertebral discs |
| BRPI0509331B8 (pt) * | 2004-03-30 | 2021-05-25 | Ilypsa Inc | uso de uma composição de ligação de sódio |
| US20060100304A1 (en) * | 2004-05-21 | 2006-05-11 | Synthes Inc. | Replacement or supplementation of a nucleus pulposus using a hydrogel |
| ES2369629T3 (es) * | 2004-05-25 | 2011-12-02 | Stryker Corporation | Uso de op-1 para tratar defectos del cartílago. |
| EP1604693A1 (en) * | 2004-06-09 | 2005-12-14 | Scil Technology GmbH | In situ forming scaffold, its manufacturing and use |
| AU2005302255A1 (en) * | 2004-10-28 | 2006-05-11 | Alza Corporation | Lyophilized liposome formulations and method |
| US20110071056A1 (en) * | 2009-09-24 | 2011-03-24 | Rajesh K Saini | Degradable Surfactants, Including Degradable Gemini Surfactants, and Associated Methods |
-
2007
- 2007-10-05 CN CN2012104557068A patent/CN102940878A/zh active Pending
- 2007-10-05 CN CNA2007800422016A patent/CN101605534A/zh active Pending
- 2007-10-05 ES ES07818736T patent/ES2708851T3/es active Active
- 2007-10-05 RS RS20130131A patent/RS52706B/sr unknown
- 2007-10-05 CA CA2664637A patent/CA2664637C/en not_active Expired - Fee Related
- 2007-10-05 SI SI200731193T patent/SI2081551T1/sl unknown
- 2007-10-05 JP JP2009530810A patent/JP5404402B2/ja not_active Expired - Fee Related
- 2007-10-05 HR HRP20130328TT patent/HRP20130328T1/hr unknown
- 2007-10-05 WO PCT/EP2007/008659 patent/WO2008040556A1/en not_active Ceased
- 2007-10-05 EP EP07818736.6A patent/EP2086507B1/en not_active Not-in-force
- 2007-10-05 EP EP07818735A patent/EP2081551B1/en active Active
- 2007-10-05 DK DK07818735.8T patent/DK2081551T3/da active
- 2007-10-05 ES ES07818735T patent/ES2400162T3/es active Active
- 2007-10-05 JP JP2009530811A patent/JP5484059B2/ja not_active Expired - Fee Related
- 2007-10-05 WO PCT/EP2007/008660 patent/WO2008040557A1/en not_active Ceased
- 2007-10-05 PT PT78187358T patent/PT2081551E/pt unknown
- 2007-10-05 RU RU2009117170/15A patent/RU2443412C2/ru not_active IP Right Cessation
- 2007-10-05 PL PL07818735T patent/PL2081551T3/pl unknown
- 2007-10-05 KR KR1020097009193A patent/KR101333279B1/ko not_active Expired - Fee Related
- 2007-10-05 CN CN2007800397245A patent/CN101528197B/zh not_active Expired - Fee Related
- 2007-10-05 TW TW096137658A patent/TWI455731B/zh not_active IP Right Cessation
-
2009
- 2009-04-06 US US12/419,167 patent/US9526761B2/en not_active Expired - Fee Related
- 2009-04-06 US US12/419,131 patent/US20090297580A1/en not_active Abandoned
-
2013
- 2013-04-18 CY CY20131100316T patent/CY1113934T1/el unknown
-
2016
- 2016-03-08 US US15/064,444 patent/US20160220638A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010505482A5 (https=) | ||
| US6268347B1 (en) | Prosaposin-derived peptides | |
| CA2801010C (en) | Peptide and use thereof for treatment of cartilage damage and arthritis | |
| ES2740826T3 (es) | Péptidos de osteopontina modificados que tienen un dominio RGD inactivado y usos de estos | |
| ES2290023T3 (es) | Moduladores de la agregacion del peptido beta-amiloide que comprenden d-aminoacidos. | |
| JP2012523438A5 (https=) | ||
| RU2008115678A (ru) | Пептиды, способные связываться с трансформирующим фактором роста бета 1 (tgf-бета 1) | |
| JP2007532510A (ja) | 上昇した血中尿素濃度を低減させるオリゴペプチド | |
| JP2009515529A5 (https=) | ||
| JPWO2010117079A1 (ja) | 神経分化誘導ペプチド及びその利用 | |
| JP2006506942A5 (https=) | ||
| US8076289B2 (en) | Fibrosis inhibitor for implanted organ | |
| EP2030984A4 (en) | DERIVED FROM SPARC CANCER EXHAUSTANTEPEPTIDE AND PHARMACEUTICALS CONTAINING THEREOF | |
| ES2304401T3 (es) | Metodos de tratamiento que utilizan polipeptidos wisp. | |
| JPWO2011152524A1 (ja) | 細胞増殖促進ペプチド及びその利用 | |
| Maerz et al. | Molecular and genetic advances in the regeneration of the intervertebral disc | |
| CN102027114A (zh) | 使用编码bmp-7的重组载体的关节软骨基因疗法 | |
| JP3786533B2 (ja) | ペプチド及び骨形成促進剤 | |
| CN102438580B (zh) | 钙结合剂诱导毛发生长和/或甲生长 | |
| JP7562167B2 (ja) | 歯周疾患または脱臼性外傷歯の予防もしくは治療用薬学的組成物 | |
| TW200800250A (en) | Protein formulation for promoting hard tissue formation | |
| JP6548126B2 (ja) | Ｉｉｉ型コラーゲン産生促進剤 | |
| FR2726472B1 (fr) | Proteine porteuse a effet adjuvant, complexe immunogene la contenant, leur procede de preparation, sequence nucleotidique et vaccin | |
| US20110274761A1 (en) | Polymer carrier | |
| ES2338350T3 (es) | Utilizacion de hsp20 para estimular la cicatrizacion de heridas y/o para reducir la formacion de cicatrices. |